281 related articles for article (PubMed ID: 29747827)
41. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).
Cleland JGF; Teerlink JR; Davison BA; Shoaib A; Metra M; Senger S; Milo O; Cotter G; Bourge RC; Parker JD; Jondeau G; Krum H; O'Connor CM; Torre-Amione G; van Veldhuisen DJ; McMurray JJV;
Eur J Heart Fail; 2017 Jun; 19(6):739-747. PubMed ID: 28296139
[TBL] [Abstract][Full Text] [Related]
42. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
[TBL] [Abstract][Full Text] [Related]
43. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.
van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL
Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029
[TBL] [Abstract][Full Text] [Related]
44. The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study.
Karlström P; Johansson P; Dahlström U; Boman K; Alehagen U
Int J Cardiol; 2017 Jun; 236():315-320. PubMed ID: 28268084
[TBL] [Abstract][Full Text] [Related]
45. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
[TBL] [Abstract][Full Text] [Related]
46. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
47. Role of BNP levels on the prognosis of decompensated advanced heart failure.
Pereira-Barretto AC; Carlo CH; Cardoso JN; Ochiai ME; Lima MV; Curiati MC; Scipioni AR; Ramires JA
Arq Bras Cardiol; 2013 Mar; 100(3):281-7. PubMed ID: 23598583
[TBL] [Abstract][Full Text] [Related]
48. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
[TBL] [Abstract][Full Text] [Related]
49. B-type natriuretic peptide and severe heart failure at baseline predict overall mortality in incident dialysis patients.
Koch M; Trapp R; Kohnle M; Aker S; Haastert B; Rump LC
Clin Nephrol; 2010 Jan; 73(1):21-9. PubMed ID: 20040348
[TBL] [Abstract][Full Text] [Related]
50. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
Shah MR; Hasselblad V; Tasissa G; Christenson RH; Binanay C; O'Connor CM; Ohman EM; Stevenson LW; Califf RM
Am J Cardiol; 2007 Nov; 100(9):1427-33. PubMed ID: 17950802
[TBL] [Abstract][Full Text] [Related]
51. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
[TBL] [Abstract][Full Text] [Related]
52. Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
Rychli K; Richter B; Hohensinner PJ; Kariem Mahdy A; Neuhold S; Zorn G; Berger R; Mörtl D; Huber K; Pacher R; Wojta J; Niessner A; Hülsmann M
Heart; 2011 Jul; 97(14):1158-63. PubMed ID: 21572126
[TBL] [Abstract][Full Text] [Related]
53. Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome.
Reardon LC; Williams RJ; Houser LS; Miner PD; Child JS; Aboulhosn JA
Am J Cardiol; 2012 Nov; 110(10):1523-6. PubMed ID: 22863176
[TBL] [Abstract][Full Text] [Related]
54. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
[TBL] [Abstract][Full Text] [Related]
55. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Hoes AW; van Veldhuisen DJ
Am Heart J; 2006 May; 151(5):1012.e1-5. PubMed ID: 16644323
[TBL] [Abstract][Full Text] [Related]
56. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.
Doust JA; Pietrzak E; Dobson A; Glasziou P
BMJ; 2005 Mar; 330(7492):625. PubMed ID: 15774989
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy.
Pitzalis MV; Iacoviello M; Di Serio F; Romito R; Guida P; De Tommasi E; Luzzi G; Anaclerio M; Varraso L; Forleo C; Pansini N
Eur J Heart Fail; 2006 Aug; 8(5):509-14. PubMed ID: 16503416
[TBL] [Abstract][Full Text] [Related]
59. N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure.
Huang YT; Tseng YT; Chu TW; Chen J; Lai MY; Tang WR; Shiao CC
Sci Rep; 2016 Jul; 6():29590. PubMed ID: 27411951
[TBL] [Abstract][Full Text] [Related]
60. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
